Latest News & Features
Asia-Pacific
Amendments to SIPO’s guidelines for the examination of utility patents may help stop the proliferation of ‘junk’ utility models in China. Wolfgang Bublak and Yingkun Brunner report. 20 June 2014
Genetics
The realm of patent eligibility under 35 USC §101 has become more confusing, with the introduction of a possible new definition of admissibility after a decision on Dolly the sheep. Nabeela Rasheed reports. 20 June 2014
Generics
There is no uniform interpretation of the scope of the Bolar exemption in Europe, but a CJEU opinion harmonising the issue may be on the way, says Rafal Witek. 20 June 2014
Americas
Holland & Knight LLP has expanded its IP practice group with the hire of patent litigator Howard Suh as partner. 18 June 2014
Americas
Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries. 16 June 2014
Americas
Drug giant Merck is to acquire biopharmaceutical company Idenix for $24.50 per share, valuing the purchase at around $3.85 billion. 12 June 2014
Generics
Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals. 10 June 2014
Big Pharma
Law firm Dechert LLP has appointed Rüdiger Herrmann as a partner in its Frankfurt office. 10 June 2014
Biotechnology
Kite Pharma, a biotech company, has entered into a licensing agreement with the US’s National Institute of Health that will give it the IP rights to T-cell therapies developed to treat cancer. 9 June 2014
Americas
AMAG Pharmaceuticals, Inc. has had a US patent covering ferumoxytol extended. 9 June 2014